Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Bizarrely Bullish: Cramer's 'Mad Money' Recap (Tuesday 11/3/20)
By Scott Rutt
Nov 3, 2020 8:18 PM EST
PRESS RELEASES
Novocure To Participate In The 39th Annual J.P. Morgan Virtual Healthcare Conference
By Business Wire
Dec 23, 2020 7:30 AM EST
PRESS RELEASES
Novocure Announces National Reimbursement In Switzerland For Optune® In Combination With Temozolomide For The Treatment Of Newly Diagnosed Glioblastoma
By Business Wire
Dec 14, 2020 1:00 AM EST
PRESS RELEASES
First Patient Enrolled In Novocure's Global Phase 3 TRIDENT Trial Of Optune® Concurrent With Radiation Therapy In Newly Diagnosed Glioblastoma
By Business Wire
Dec 10, 2020 7:30 AM EST
PRESS RELEASES
Novocure To Participate In The Evercore ISI 2020 Virtual HealthCONx Conference
By Business Wire
Nov 25, 2020 7:30 AM EST
PRESS RELEASES
Novocure Announces 43 Presentations On Tumor Treating Fields At Society For Neuro-Oncology 2020 Virtual Annual Meeting
By Business Wire
Nov 19, 2020 8:00 AM EST
PRESS RELEASES
Novocure Receives CE Mark For NovoTTF-100L™ System
By Business Wire
Nov 11, 2020 7:30 AM EST
PRESS RELEASES
Novocure Announces Agenda For Virtual Research And Development Day
By Business Wire
Nov 10, 2020 7:30 AM EST
PRESS RELEASES
Novocure Announces Closing Of $150 Million Revolving Credit Facility With A Syndicate Of Relationship Banks
By Business Wire
Nov 9, 2020 7:30 AM EST
JIM CRAMER
Bizarrely Bullish: Cramer's 'Mad Money' Recap (Tuesday 11/3/20)
By Scott Rutt
Nov 3, 2020 8:18 PM EST
PRESS RELEASES
Novocure Announces Proposed Private Placement Of $500 Million Of Convertible Senior Notes
By Business Wire
Nov 2, 2020 7:04 AM EST
PRESS RELEASES
Novocure Announces Strategic Alliance With NYU Grossman School Of Medicine For Preclinical And Clinical Research
By Business Wire
Oct 29, 2020 6:00 AM EDT
PRESS RELEASES
Novocure To Report Third Quarter 2020 Financial Results
By Business Wire
Oct 2, 2020 8:56 AM EDT
PRESS RELEASES
Novocure Honors Mesothelioma Day With Activities To Raise Awareness Of Mesothelioma And Support The Community
By Business Wire
Sep 25, 2020 4:00 PM EDT
PRESS RELEASES
Novocure To Participate In The 2020 Wells Fargo Virtual Healthcare Conference
By Business Wire
Sep 4, 2020 7:30 AM EDT
PRESS RELEASES
Novocure Announces Recipients Of 2nd Annual AACR-Novocure Grants For Tumor Treating Fields Research Program
By Business Wire
Jul 28, 2020 7:30 AM EDT
PRESS RELEASES
First Patient Enrolled In Novocure's EF-33 Phase 2 Pilot Trial Of Tumor Treating Fields Delivered Utilizing High-Intensity Transducer Arrays
By Business Wire
Jul 22, 2020 7:30 AM EDT
PRESS RELEASES
Novocure Announces Clinical Trial Collaboration With MSD To Evaluate Tumor Treating Fields Together With KEYTRUDA® (pembrolizumab) In Non-Small Cell Lung Cancer
By Business Wire
Jul 15, 2020 7:30 AM EDT
PRESS RELEASES
Novocure Announces Over 100 Physicians In The U.S. Now Certified To Prescribe Optune Lua™
By Business Wire
Jul 8, 2020 7:30 AM EDT
PRESS RELEASES
Novocure Enrolls Last Patient In HEPANOVA Trial Testing Tumor Treating Fields In Combination With Sorafenib In Advanced Liver Cancer
By Business Wire
Jul 7, 2020 7:30 AM EDT
PRESS RELEASES
Novocure To Report Second Quarter 2020 Financial Results
By Business Wire
Jul 1, 2020 7:30 AM EDT
PRESS RELEASES
Novocure Announces Launch Of MyLink™ To Enable Patient-Guided, Remote Download Of Optune® Usage Data
By Business Wire
Jun 2, 2020 7:30 AM EDT
PRESS RELEASES
Novocure Announces Presentation Of EF-19 Post-approval Registry Trial Data Studying Optune As A Monotherapy For The Treatment Of Recurrent GBM At The American Association For Cancer Research 2020 Virtual Annual Meeting I
By Business Wire
Apr 27, 2020 7:30 AM EDT
PRESS RELEASES
Novocure Provides Business Update Related To COVID-19
By Business Wire
Apr 3, 2020 7:30 AM EDT
PRESS RELEASES
German Federal Joint Committee Updates Medical Care Directive To Include Tumor Treating Fields, Establishing National Reimbursement For Optune In Germany
By Business Wire
Mar 20, 2020 9:16 AM EDT
